Browsing Tag
Jonathan D. Alspaugh
1 post
Aeglea BioTherapeutics buys Spyre Therapeutics to revolutionize IBD treatment
Aeglea BioTherapeutics, a Nasdaq-listed company, has acquired Spyre Therapeutics, a private biotech company dedicated to advancing a promising…